Markus Stock, Head of Medical Physics at EBG MedAustron, says: “MedAustron started its clinical operation with RayStation as treatment planning system for protons and carbon ions in 2016. We trusted in RaySearch to fulfill our clinical requirements for a high-quality patient care at our facility. It was a logical next step for us to integrate RaySearch software technology beyond treatment planning by switching to RayCommand, bringing a well-integrated treatment control system to our environment.”

RayCommand is the result of a close working partnership between the RaySearch, AVO and MedAustron. After 18 months of intense development and integration with different systems, successful testing took place in December 2020 at AVO and MedAustron.


David Clerk, AVO V&V Test Engineer, says: “After concluding our feasibility testing, it is wonderful to see that we have an integrated suite of RaySearch products that can seamlessly take a patient through the main stages of the LIGHT proton therapy workflow, from their entrance to the clinic through to the proton therapy treatment. “

Johannes Hopfgartner, Medical Physicist, EBG MedAustron, says: “After a series of intense integration shifts in our gantry room, it was a big deal to see the in-room components, such as gantry, snout, nozzle filters and patient positioner, being orchestrated by RayCommand and reaching their planned destinations with the correct parameter settings. Successful communication of RayCommand with the MedAustron Accelerator MAPTA concluded an efficient integration period. A perfect pre-Christmas present for the whole team!”

Johan Löf, founder and CEO, RaySearch, says: “The development of RayCommand is a natural step for RaySearch. Until now, every machine manufacturer has had to develop its own systems for the control and treatment rooms. These systems fulfill essentially the same function. RayCommand enables a more consistent user experience regardless of the type of treatment machine. It also makes it easier for new machine manufacturers to establish themselves in the market, which I believe is vital to facilitate innovation, increase competition in our industry and improve cancer care.”


About Advanced Oncotherapy
Advanced Oncotherapy plc (AVO) is a provider of particle therapy with protons that harnesses the best in modern technology. AVO focuses on the development of a proprietary proton accelerator called Linac for Image Guided Hadron Technology (LIGHT). LIGHT’s compact configuration delivers proton beams in a way that facilitates greater precision and electronic control. AVO will offer healthcare providers affordable systems that will enable them to treat cancer with innovative technology and reduce treatment-related side effects. More information: https://www.avoplc.com/en-gb/

Health IT Homepage